Sign in
NXLIW Stock Price, Chart, Stats & News
Nexalin Technology, Inc.
Save
Nexalin Technology, Inc. (NXLIW) does not currently pay a dividend.
283,160
Market cap
–
Current P/E
–
Forward P/E
NXLIW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -310.29% |
Operating margin | -2781.69% |
Pretax margin | -2725.76% |
Net margin | -2725.76% |
Effective tax rate | – |
ROA | -177.38% |
ROE | -195.71% |
D/E | – |
Interest coverage ratio | – |
NXLIW valuation
P/E | – |
P/S | 24.85x |
P/B | 1.81x |
P/CF | -1.37x |
P/FCF | -1.51x |
P/OCF | -1.37x |
PEG | -0.03x |
EV multiple | -0.99x |
About
Based in Houston, Texas, Nexalin Technology, Inc., founded in 2021, is a medical device firm dedicated to creating and advancing neurostimulation solutions. These products are designed to address mental health conditions within the United States and China. The company's primary offering, the Nexalin Device, is a licensed, non-invasive, and drug-free therapeutic option for managing anxiety and insomnia.
Similar securities
Based on sector and market capitalization
Report issue